Julie Nonnekens - Search Results

Year	Number of Results
2009	1
2011	1
2012	1
2013	3
2015	2
2016	4
2017	2
2018	2
2019	7
2020	8
2021	10
2022	11
2023	5
2024	0

1

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients.

Ladan MM, Meijer TG, Verkaik NS, de Monye C, Koppert LB, Oomen-de Hoop E, van Deurzen CHM, Kanaar R, Nonnekens J, van Gent DC, Jager A. Ladan MM, et al. Among authors: nonnekens j. NPJ Breast Cancer. 2023 Sep 30;9(1):80. doi: 10.1038/s41523-023-00583-6. NPJ Breast Cancer. 2023. PMID: 37777518 Free PMC article.

2

Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy.

Nonnekens J, Cornelissen B, Terry SYA; European Working Group on the Radiobiology of Molecular Radiotherapy. Nonnekens J, et al. J Nucl Med. 2023 Nov;64(11):1788-1790. doi: 10.2967/jnumed.123.265956. Epub 2023 Jul 13. J Nucl Med. 2023. PMID: 37442600

3

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo.

Reuvers TGA, Verkaik NS, Stuurman D, de Ridder C, Groningen MCC, de Blois E, Nonnekens J. Reuvers TGA, et al. Among authors: nonnekens j. Theranostics. 2023 May 21;13(10):3117-3130. doi: 10.7150/thno.82963. eCollection 2023. Theranostics. 2023. PMID: 37351169 Free PMC article.

4

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib.

Feijtel D, Reuvers TGA, van Tuyll-van Serooskerken C, de Ridder CMA, Stuurman DC, de Blois E, Verkaik NS, de Bruijn P, Koolen SLW, de Jong M, Nonnekens J. Feijtel D, et al. Among authors: nonnekens j. Cancers (Basel). 2023 Feb 1;15(3):915. doi: 10.3390/cancers15030915. Cancers (Basel). 2023. PMID: 36765883 Free PMC article.

5

A Clinical Guide to Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE in Neuroendocrine Tumor Patients.

Becx MN, Minczeles NS, Brabander T, de Herder WW, Nonnekens J, Hofland J. Becx MN, et al. Among authors: nonnekens j. Cancers (Basel). 2022 Nov 24;14(23):5792. doi: 10.3390/cancers14235792. Cancers (Basel). 2022. PMID: 36497273 Free PMC article. Review.

6

Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [¹⁷⁷Lu]Lu-PSMA.

Hooijman EL, Ntihabose CM, Reuvers TGA, Nonnekens J, Aalbersberg EA, van de Merbel JRJP, Huijmans JE, Koolen SLW, Hendrikx JJMA, de Blois E. Hooijman EL, et al. Among authors: nonnekens j. EJNMMI Radiopharm Chem. 2022 Nov 4;7(1):29. doi: 10.1186/s41181-022-00181-0. EJNMMI Radiopharm Chem. 2022. PMID: 36333648 Free PMC article.

7

Feasibility of bevacizumab-IRDye800CW as a tracer for fluorescence-guided meningioma surgery.

Dijkstra BM, Nonnekens J, Nagengast W, Kruijff S, Meersma GJ, den Dunnen WFA, Kruyt FAE, Groen RJM. Dijkstra BM, et al. Among authors: nonnekens j. J Neurosurg. 2022 Oct 28;138(5):1263-1272. doi: 10.3171/2022.9.JNS221036. Print 2023 May 1. J Neurosurg. 2022. PMID: 36308486

8

Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors.

Koustoulidou S, Handula M, de Ridder C, Stuurman D, Beekman S, de Jong M, Nonnekens J, Seimbille Y. Koustoulidou S, et al. Among authors: nonnekens j. Pharmaceuticals (Basel). 2022 Sep 16;15(9):1155. doi: 10.3390/ph15091155. Pharmaceuticals (Basel). 2022. PMID: 36145375 Free PMC article.

9

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment.

Ruigrok EAM, Verkaik NS, de Blois E, de Ridder C, Stuurman D, Roobol SJ, Van Gent DC, de Jong M, Van Weerden WM, Nonnekens J. Ruigrok EAM, et al. Among authors: nonnekens j. Int J Mol Sci. 2022 Jul 21;23(14):8037. doi: 10.3390/ijms23148037. Int J Mol Sci. 2022. PMID: 35887398 Free PMC article.

10

Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T.

Ruigrok EAM, Tamborino G, de Blois E, Roobol SJ, Verkaik N, De Saint-Hubert M, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: nonnekens j. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3956-3957. doi: 10.1007/s00259-022-05845-2. Eur J Nucl Med Mol Imaging. 2022. PMID: 35614268 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

49 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year